Our mission
People living with Crohn’s deserve a resource that takes natural and holistic approaches seriously. Crohn’s Wellness exists to be that resource: a supportive guide to the botanicals, nutrients and emerging therapies that people are using to care for their gut, grounded in research and powered by the experience of our community.
The research gap we’re here to close
Large clinical trials cost tens to hundreds of millions of dollars, and they’re almost always funded by companies that can patent what they’re testing. Turmeric, wormwood, fish oil and zinc can’t be patented. So even when early studies are promising, the large follow-up trials that would settle the question often never happen.
That leaves people with Crohn’s without answers to the questions they care about most. What actually helps? At what dose? For people like me? We don’t think the absence of a billion-dollar trial should mean the absence of information.
That’s why we’re building a Community Symptom Tracker. People living with Crohn’s will be able to log what they take and how they feel. Together, those logs will form the real-world dataset traditional research funding hasn’t produced.
What you’ll find here
- 20 in-depth profiles of natural therapies and nutrient protocols for gut health
- How each one works, its traditional history, and what the research shows, with every study linked
- 53 research sources you can read for yourself
- Practical guidance on choosing quality products: the right form, standardisation and testing
- Tips for working alongside your care team, including medication interactions to watch for
How we describe the research
Each profile carries a research-stage label, so you can see at a glance how far the science has come. A label describes where the research is today. It isn’t a verdict on whether something might help you.
- Clinically studied
- Tested in multiple controlled human trials in IBD, with encouraging results. One of the better-researched natural options available.
- Mixed clinical results
- Human trials exist with both encouraging and neutral findings. Individual response varies — exactly the gap real-world patient data can help close.
- Early clinical research
- Promising results from smaller or pilot human studies. Large trials have not been funded yet, which is common for non-patentable natural compounds.
- Emerging research
- Strong mechanistic rationale and laboratory research. Human trials in Crohn’s disease are still pending.
How we’re funded
Our research summaries are free. We support the site through affiliate links and advertising: when you buy a product through one of our retailer links, we may earn a small commission at no extra cost to you. Those funds go into keeping the content free and building the community tracker.
Commercial relationships never decide which compounds we cover, how we describe the research, or what we recommend looking for in a product. Read our full affiliate disclosure.
Working with your care team
We believe natural support and conventional care work best together. Most of the research on this site studied natural compounds alongside standard treatment, and that’s how we encourage people to use them: openly, with a gastroenterologist who knows everything you’re taking.
Phase 2 — in development
Where traditional research stops, our community begins
Natural compounds can’t be patented, so they rarely get the multi-million-dollar trials that drugs receive. That leaves people with Crohn’s without answers to the questions that matter most: what actually helps, at what dose, and for whom? Our Community Symptom Tracker will crowdsource those answers from real people living with Crohn’s, and our upcoming wellness store will make it easy to find quality, third-party-tested products.
- Log your symptoms, supplements and doses in a private daily tracker
- See what’s working for people with the same disease location and medications
- Contribute to the largest real-world dataset on natural Crohn’s support
- Shop curated, third-party-tested protocols from our upcoming store
Be one of the first to join
Early access is opening soon. Bookmark this page and check back — we’ll announce sign-ups here first.